Zoono Group Overview
- Status
-
Public
- Employees
-
13

- Stock Symbol
-
ZNO

- Share Price
-
$0.02
- (As of Friday Closing)
Zoono Group General Information
Description
Zoono Group Ltd is engaged in the research, development, and sale of a range of antimicrobial products in multiple countries. The company develops products suited for skin care, surface sanitizers, aerosol-based sprays, as well as acne products, and mold remediation treatments. Geographically, it derives a majority of its revenue from Australasia, Asia, the United States, and India, and also has a presence in the United Kingdom and Europe.
Contact Information
Website
www.zoono.co.nzCorporate Office
- Unit 3- 24 Bishop Dunn Place
- Botany South
- Auckland, 2013
- New Zealand
Corporate Office
- Unit 3- 24 Bishop Dunn Place
- Botany South
- Auckland, 2013
- New Zealand
Zoono Group Stock Performance
As of 20-Jun-2025, Zoono Group’s stock price is $0.02. Its current market cap is $6.68M with 355M shares.
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$0.02 | $0.02 | $0.01 - $0.05 | $6.68M | 355M | 735K |
Zoono Group Financials Summary
As of 31-Mar-2025, Zoono Group has a trailing 12-month revenue of null.
In Thousands, USD |
TTM 31-Mar-2025 | FY 2024 30-Jun-2024 | FY 2023 30-Jun-2023 | FY 2022 30-Jun-2022 |
---|---|---|---|---|
EV | 5,765 | 6,906 | 4,849 | 12,221 |
Revenue | 636 | 2,051 | 6,122 | |
EBITDA | (5,386) | (287) | (8,369) | |
Net Income | (5,509) | (215) | (7,738) | |
Total Assets | 5,990 | 8,836 | 12,184 | |
Total Debt | 483 | 573 | 692 |
Zoono Group Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Zoono Group Patents
Zoono Group Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2022291538-A1 | Methods and articles for keeping food fresher for longer and shelf-life extension to enhance food security and safety | Pending | 18-Mar-2022 | ||
EP-4252545-A1 | Methods and articles for keeping food fresher for longer and shelf-life extension to enhance food security and safety | Pending | 18-Mar-2022 | ||
AU-2021273543-A1 | Surface disinfectant and hand sanitizer combatting contact spread | Pending | 19-Feb-2021 | ||
CA-3149438-A1 | Surface disinfectant and hand sanitizer combatting contact spread | Pending | 19-Feb-2021 | ||
US-20220265894-A1 | Antibiofilm compositions, wound dressings, cleaning methods and treatment methods | Pending | 19-Feb-2021 | A01N31/14 |
Zoono Group Signals
Zoono Group Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Zoono Group FAQs
-
Where is Zoono Group headquartered?
Zoono Group is headquartered in Auckland, New Zealand.
-
What is the size of Zoono Group?
Zoono Group has 13 total employees.
-
What industry is Zoono Group in?
Zoono Group’s primary industry is Drug Discovery.
-
Is Zoono Group a private or public company?
Zoono Group is a Public company.
-
What is Zoono Group’s stock symbol?
The ticker symbol for Zoono Group is ZNO.
-
What is the current stock price of Zoono Group?
As of 20-Jun-2025 the stock price of Zoono Group is $0.02.
-
What is the current market cap of Zoono Group?
The current market capitalization of Zoono Group is $6.68M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »